The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.
about
Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyA systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based?Risk of medication overuse headache across classes of treatments for acute migraineQuantitative oculomotor findings in migrainous patientsSingle-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot programMedication overuse in Moldova. Chronic migraine with and without medication overuse: the role of drug phobia and associated factors (according to the data of Headache Centre, Chisinau, the Republic of Moldova).The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved?Abnormal cortical responses to somatosensory stimulation in medication-overuse headache.Medication-overuse headache: a reviewIncreased susceptibility to cortical spreading depression in an animal model of medication-overuse headacheSoluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosisUnilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias.Management of secondary chronic headache in the general population: the Akershus study of chronic headache.Pericranial tenderness in chronic tension-type headache: the Akershus population-based study of chronic headache.Dependency-like behaviors and pain coping styles in subjects with chronic migraine and medication overuse: results from a 1-year follow-up study.The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders.Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial.Study protocol: brief intervention for medication overuse headache--a double-blinded cluster randomised parallel controlled trial in primary care.Trigger factors and premonitory features of migraine attacks: summary of studies.Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol).Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache.Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse.Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.Feasibility of a brief intervention for medication-overuse headache in primary care--a pilot study.Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trialChronic migraine plus medication overuse headache: two entities or not?Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial.Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A.Management of primary chronic headache in the general population: the Akershus study of chronic headacheChronic daily headaches.From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries.Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk.Associations between sleep disturbance and primary headaches: the third Nord-Trøndelag Health Study.Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphismMedication overuse headache: a critical review of end points in recent follow-up studies.Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraineDifferences in Clinical Features and Disability according to the Frequency of Medication Use in Patients with Chronic Migraine.A narrative review on the management of medication overuse headache: the steep road from experience to evidence.
P2860
Q24633546-D35E250F-F0D2-48D4-8F90-000F6EF2B389Q26858984-4D112F80-AD68-414C-949F-1FB2A3D48551Q28070421-55D9C96A-ED72-4BDB-8320-D973A29C2B5FQ30420208-4CF5F199-7ACC-4875-B9C0-FC8D6FFC595DQ30968082-AA1713BD-65B1-4F89-99DF-C2E6DB2C80D0Q33382494-F63F53D2-26FA-4222-AAE5-6BE8CBCDF63EQ33654152-598FC0A7-FBC3-42F2-B0A1-9F76971AAB22Q33727548-2AE4CC61-614E-43D7-A5F4-02E5F694C885Q33782357-A2D8B672-5BE5-418E-A4A7-D6321911F304Q33838844-E49CA1F8-4360-45E9-A442-B9733E9E6BA4Q33921986-5CF96DFD-F7FF-4900-859B-BC43BD1241ABQ33999870-AFD48427-E3F6-4303-A35E-F2445EFB90A5Q34011201-02A66203-CEC2-4226-A4C8-44F9AD1BABA8Q34036249-6F66D135-88AC-4C69-933F-6C88A2ADD16CQ34194885-5584AE5E-A830-426F-B1CD-5DD2629F8D39Q34233726-212D2D6A-633A-410D-8CF3-9B8393376BBFQ34304978-AAE989CB-7BD5-444F-8460-99D8551BBF98Q34306281-E08AB112-9DE7-41CB-8598-60394BD3E320Q34375888-45E76065-996D-4072-AA8B-F2F77DC90A78Q34448071-903A8463-F66A-4C97-AA1D-0D8B8F8CDFC2Q34806387-0C1BB250-D037-4004-9360-6E5CCE70AFFDQ34885957-8AECB72A-DD49-4AF1-8134-CB423CB906C3Q35008071-04CCC8B6-C949-4F5B-B6AA-4F3149DBDC40Q35113481-126852C8-EF3D-40F0-BB8E-6EF2A6FB20C6Q35116532-B768A0A6-A373-4391-A696-16BBB05F63C0Q35124817-318F1CD7-17A1-4D4F-B33E-91CF5590EBDFQ35202574-541D8194-2755-483E-86D1-D4D94C614F4EQ35522746-1504FBA9-47EC-4784-9622-CBB8F0CD9FE6Q35550702-BB40ED8D-8AF9-41C4-AC5D-4B3348C39C63Q35697217-E0645421-4438-4BD2-9F73-EF8DCAEA54EEQ35742557-971EF578-8D53-4BCB-9E9E-6316A94B8C35Q36239475-82556529-908C-4AD4-9D38-315CFB372852Q36259584-B93992FD-484C-47E6-8DD7-11945F4D7096Q36259780-A10F1142-81A6-4040-BC4E-EF06EB2D5F6BQ36260189-976D2370-CA9B-404E-B7DC-30D8242233FCQ36260675-952DBCE1-3424-49B9-A511-06675ABFAFDDQ36261109-23C39A0A-3190-41CC-825D-5ED993D60BA1Q36261128-B8D3C5F9-0632-4355-BF4C-04B29C6B9449Q36313097-8C0C18CF-6D99-4030-B722-597A5052B735Q36332629-6146C31B-C97E-4A23-AAEE-3156F82CD86D
P2860
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The International Classificati ...... 2 Medication-overuse headache.
@ast
The International Classificati ...... 2 Medication-overuse headache.
@en
The International Classificati ...... 2 Medication-overuse headache.
@nl
type
label
The International Classificati ...... 2 Medication-overuse headache.
@ast
The International Classificati ...... 2 Medication-overuse headache.
@en
The International Classificati ...... 2 Medication-overuse headache.
@nl
prefLabel
The International Classificati ...... 2 Medication-overuse headache.
@ast
The International Classificati ...... 2 Medication-overuse headache.
@en
The International Classificati ...... 2 Medication-overuse headache.
@nl
P2093
P2860
P50
P1433
P1476
The International Classificati ...... 2 Medication-overuse headache.
@en
P2093
H-C Diener
International Headache Society
J Schoenen
M J A Lainez
M-G Bousser
P2860
P304
P356
10.1111/J.1468-2982.2005.00878.X
P407
P577
2005-06-01T00:00:00Z